Higher-Dose Ivermectin for Outpatients With COVID-19, Trends in Cardiovascular Risk Factor Prevalence and Control in US Adults, Review of Chronic Lymphocytic Leukemia, and more

JAMA Editor’s Summary

Higher-Dose Ivermectin for Outpatients With COVID-19, Trends in Cardiovascular Risk Factor Prevalence and Control in US Adults, Review of Chronic Lymphocytic Leukemia, and more

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the issue.

March 21, 2023

Listen on your favorite player Take me to this show’s page

Newer →

Tight Glycemic Control and Use of Verapamil in Pediatric Type 1 Diabetes, US Trends in Pediatric Mental Health Hospitalizations, Evaluation for Secondary Hypertension in Children, and more

← Older

Atrial Pacing for Heart Failure With Preserved Ejection Fraction, Insurance Gender Nondiscrimination Act and Gender-Affirming Surgery in California, Review of Heart Failure With Preserved Ejection Fraction, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Higher-Dose Ivermectin for Outpatients With COVID-19, Trends in Cardiovascular Risk Factor Prevalence and Control in US Adults, Review of Chronic Lymphocytic Leukemia, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the March 21, 2023 issue.

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00